NCT07135323View on ClinicalTrials.gov

AvertD Post-Approval Study

RecruitingOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

November 30, 2031

Study Completion Date

November 30, 2031

Conditions
Opioid Use Disorder
Interventions
GENETIC

Opioid Used Disorder Risk Assessment

Determine the likelihood of Opioid Used Disorder prior to prescribing opioids

Trial Locations (1)

46240

RECRUITING

Concentrics Research, Indianapolis

Sponsors

Collaborators (1)

Concentrics Research
All Listed Sponsors
collaborator

Caron Treatment Centers

OTHER

collaborator

Concentrics Research

OTHER

lead

Prescient Medicine Holdings, Inc.

INDUSTRY